Category: Antibody Technologies
Antibody Technologies market research reports by Icon Group International, Inc.
-
The 2023-2028 World Outlook for Mammalian Polyclonal IgG Antibodies
The 2023-2028 World Outlook for Mammalian Polyclonal IgG Antibodies This study covers the world outlook for mammalian polyclonal IgG antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2023-2028 World Outlook for Monoclonal Antibodies
The 2023-2028 World Outlook for Monoclonal Antibodies This study covers the world outlook for monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2023-2028 World Outlook for Research Antibodies and Reagents
The 2023-2028 World Outlook for Research Antibodies and Reagents This study covers the world outlook for research antibodies and reagents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2023-2028 World Outlook for Antibody Services
The 2023-2028 World Outlook for Antibody Services This study covers the world outlook for antibody services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies This study covers the world outlook for AntiCD20 monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2023-2028 World Outlook for Cancer Immunotherapy Monoclonal Antibodies
The 2023-2028 World Outlook for Cancer Immunotherapy Monoclonal Antibodies This study covers the world outlook for cancer immunotherapy monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2023-2028 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
The 2023-2028 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes This study covers the world outlook for intravenous immunoglobulin for guillain-Barre syndromes across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2023-2028 World Outlook for Immunoglobulin Diagnostic Tests
The 2023-2028 World Outlook for Immunoglobulin Diagnostic Tests This study covers the world outlook for immunoglobulin diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2023-2028 World Outlook for Next Generation Antibody Therapeutics
The 2023-2028 World Outlook for Next Generation Antibody Therapeutics This study covers the world outlook for next generation antibody therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2023-2028 World Outlook for Albumin Plasma Protein Therapeutics
The 2023-2028 World Outlook for Albumin Plasma Protein Therapeutics This study covers the world outlook for albumin plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2023-2028 World Outlook for Cell Surface Marking Antibodies
The 2023-2028 World Outlook for Cell Surface Marking Antibodies This study covers the world outlook for cell surface marking antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2023-2028 World Outlook for Monoclonal Antibody (MAb)-Based Products
The 2023-2028 World Outlook for Monoclonal Antibody (MAb)-Based Products This study covers the world outlook for monoclonal antibody (MAb)-based products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2023-2028 World Outlook for Immunohistochemistry Antibodies
The 2023-2028 World Outlook for Immunohistochemistry Antibodies This study covers the world outlook for immunohistochemistry antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2023-2028 World Outlook for Antibody Library Technologies
The 2023-2028 World Outlook for Antibody Library Technologies This study covers the world outlook for antibody library technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2023-2028 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)
The 2023-2028 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2023-2028 World Outlook for Custom Antibodies
The 2023-2028 World Outlook for Custom Antibodies This study covers the world outlook for custom antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2023-2028 World Outlook for Monoclonal Antibodies Market in Breast Cancers
The 2023-2028 World Outlook for Monoclonal Antibodies Market in Breast Cancers This study covers the world outlook for monoclonal antibodies market in breast cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2023-2028 World Outlook for Phage Display Antibody Library Technologies
The 2023-2028 World Outlook for Phage Display Antibody Library Technologies This study covers the world outlook for phage display antibody library technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2023-2028 World Outlook for Research Antibodies
The 2023-2028 World Outlook for Research Antibodies This study covers the world outlook for research antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2023-2028 World Outlook for Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Inhibitors
The 2023-2028 World Outlook for Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Inhibitors This study covers the world outlook for programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors across more than 190 countries. For each year reported, estimates are given fo ... Read More
-
The 2023-2028 World Outlook for Biologicals
The 2023-2028 World Outlook for Biologicals This study covers the world outlook for biologicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies (mAb) This study covers the world outlook for biosimilar monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies This study covers the world outlook for biosimilar monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
Research Assistance
